HOME Research Insight Key Players in the Regenerative medicine Market Focus on New Product Launches, Expansions, Acquisitions, Partnerships, Agreements, & Collaborations



Key Players in the Regenerative medicine Market Focus on New Product Launches, Expansions, Acquisitions, Partnerships, Agreements, & Collaborations


The Regenerative medicine market is expected to reach USD 38.70 Billion by 2021 from USD 13.41 Billion in 2016 at a CAGR of 23.6%. government and private funding to support the development of regenerative medicine, rising prevalence of chronic diseases and genetic disorders, increase in global healthcare expenditure, and rapid growth in the aging population has led to the wide application of Regenerative medicine products, thus driving their market growth

The Regenerative medicine market is consolidated in nature due to the presence of a wide number of players. The key players in the cell-based products segment are Organogenesis Inc. (U.S.), Osiris Therapeutics, Inc. (U.S.), Vericel Corporation (U.S.), Stryker Corporation (U.S.), and NuVasive, Inc. (U.S.). The key players in the acellular products segment are Medtronic (Ireland), Acelity (KCI Concepts) (U.S.), Integra LifeSciences (U.S.), Cook Biotech Inc. (U.S.), and C.R. Bard (U.S.).

Based on cell-based products, Organogenesis Inc. (U.S.) leads the global Regenerative medicine market in 2015. In January 2014, Organogenesis purchased the Dermagraft portfolio (human fibroblast-derived dermal substitute) from Shire plc (Dublin). Dermagraft is approved for the treatment of non-healing diabetic foot ulcers in the U.S. and Canada. NuVasive, Inc. (U.S.) Ranked 2nd in the global Regenerative medicine market in 2015.For instance, NuVasive (U.S.) announced its plans to acquire Ellipse Technologies (U.S.), a private company providing procedural solutions for complex skeletal deformity, for a sum of USD 380 Million in 2017. This will enable the company to strengthen its product offerings as well as enhance its market reach.

Based on acellular products, Acelity (KCI Concepts) leads the global Regenerative medicine market in 2015. This company focusses in agreements and acquisitions to expand its market. For instance, in Febraury 2016, Acelity partnered with Mediq (Netherlands), a leading homecare and medical device delivery company. Under the terms of this agreement, Mediq will distribute Acelity’s advanced wound care and regenerative medicine portfolio in Denmark, Finland, Norway, and Sweden. With this partnership, Acelity gained access to Mediq’s specialized knowledge, expertise, and network in the region. While, Integra LifeSciences (U.S.), accounted for the 2nd rank in the global Regenerative medicine market in 2015. This company also focusses on acquisitions to expand its market. For instance, Integra LifeSciences Corporation announced that it had signed a definitive agreement to acquire Derma Sciences Inc. (U.S.) for a price of USD 7.00 per share of Derma Sciences common stock in cash. The addition of the amniotic tissue-based platform technology of Derma Sciences would further extend Integra's regenerative technology capabilities and build upon its 3x3 wound care strategy.

The key strategies followed by most companies in the Regenerative medicine market are acquisitions and partnerships. These strategy accounted for the largest share of the overall growth strategies mapped from 2013 to 2016.Some of the leading players that adopted this strategy include NuVasive Inc. (U.S.) , Integra LifeSciences Corporation(U.S.), Medtronic plc (Ireland), Organogenesis Inc. (U.S.),among others.

Besides, there are developments like acquisition; agreements, collaboration, and partnerships; product launches; expansion; and others to strengthen their market presence.

Related Reports:

Regenerative Medicine Market by Therapy (Cell Therapy, Tissue Engineering, Immunotherapy, Gene Therapy), Product (Cell-Based, Acellular), Applications (Orthopedic & Musculoskeletal Disorders, Dermatology, Oncology, Cardiology) - Forecast to 2021

Contact:
Mr.Rohan
MarketsandMarkets™
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports